| For: | Huang LL, Yu XP, Li JL, Lin HM, Kang NL, Jiang JJ, Zhu YY, Liu YR, Zeng DW. Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection. World J Gastroenterol 2021; 27(7): 641-653 [PMID: 33642834 DOI: 10.3748/wjg.v27.i7.641] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i7/641.htm |
| Number | Citing Articles |
| 1 |
Seyed Hamid Moosavy, Ebrahim Eftekhar, Parivash Davoodian, Abdolazim Nejatizadeh, Mohammad Shadman, Shahram Zare, Mirza Ali Nazarnezhad. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02780-w
|
| 2 |
Fei-Xiang Xiong, Lei Sun, Xue-Jie Zhang, Jia-Liang Chen, Yang Zhou, Xiao-Min Ji, Pei-Pei Meng, Tong Wu, Xian-Bo Wang, Yi-Xin Hou. Machine learning-based models for advanced fibrosis in non-alcoholic steatohepatitis patients: A cohort study. World Journal of Gastroenterology 2025; 31(9): 101383 doi: 10.3748/wjg.v31.i9.101383
|
| 3 |
Shafei Liu, Conggao Peng, Shijia Xia, Chaonan Li, Xiahong Dai, Xingyu Liu, Meng Zhang, Xiaoping Li, Lingling Tang. Chitinase 3-like protein 1: a diagnostic biomarker for early liver fibrosis in autoimmune liver diseases. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1504066
|
| 4 |
Nermeen Samy, Dalia Fayez, Emad Kelada, Dalia Mostafa Mohamed Sdik, Nouran M. Elshahat, Maha Ahmed El-Serwi. Liver fibrosis assessment in rheumatoid arthritis patients on long-term methotrexate therapy using hepatic fibroScan (transient elastography). The Egyptian Rheumatologist 2026; 48(1) doi: 10.1016/j.ejr.2026.01.001
|
| 5 |
Ruveena Bhavani Rajaram, Thevaraajan Jayaraman, Xin‐Hui Khoo, Nalliah Saravanaa, Anjanna Kukreja, Bushra Megat Johari, Nadia Fareeda Muhammad Gowdh, Wai‐Kin Lee, Choong‐Yeong Sooi, Sazali Basri, Rong‐Xiang Ng, Hang‐Cheng Ong, Pui‐Li Wong, Sharifah Faridah Syed Omar, Sanjiv Mahadeva. Liver dysfunction in adults with COVID‐19 infection: A longitudinal study with transient elastography evaluation. JGH Open 2024; 8(8) doi: 10.1002/jgh3.13118
|
| 6 |
Lilian Yan Liang, Terry Cheuk‐Fung Yip, Jimmy Che‐To Lai, Amy Shuk‐Man Lam, Yee‐Kit Tse, Vicki Wing‐Ki Hui, Henry Lik‐Yuen Chan, Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong. Dynamic Changes in ELF Score Predict Hepatocellular Carcinoma in Chronic Hepatitis B Patients Receiving Antiviral Treatment. Journal of Viral Hepatitis 2024; 31(12) doi: 10.1111/jvh.14004
|
| 7 |
Valentina Peta, Yuliya Sandler, Olivier Deckmyn, Oksana Duroselle, Elena Vinnitskaya, Sergey Khomeriki, Karina Noskova, Thierry Poynard. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference. World Journal of Hepatology 2025; 17(3): 104534 doi: 10.4254/wjh.v17.i3.104534
Abstract(455) |
Core Tip(416) |
Full Article(HTML)(1302)
|
Full Article (PDF)-1322K(137)
|
Full Article with Cover (PDF)-1606K(244)
|
Full Article (XML)-156K(138)
|
Audio-665K(22)
|
Peer-Review Report-221K(98)
|
Answering Reviewers-336K(107)
|
Supplementary Material-182K(91)
|
Times Cited (2)
|
Total Visits (2642)
|
Open
|
| 8 |
Mette Munk Lauridsen, Kim Ravnskjaer, Lise Lotte Gluud, Arun J. Sanyal. Disease classification, diagnostic challenges, and evolving clinical trial design in MASLD. Journal of Clinical Investigation 2025; 135(10) doi: 10.1172/JCI189953
|
| 9 |
Andres Duarte-Rojo, Bachir Taouli, Daniel H. Leung, Deborah Levine, Tarek Nayfeh, Bashar Hasan, Yahya Alsawaf, Samer Saadi, Abdul Mounaem Majzoub, Apostolos Manolopoulos, Samir Haffar, Ayca Dundar, M. Hassan Murad, Don C. Rockey, Mouaz Alsawas, Richard K. Sterling. Imaging-based noninvasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline. Hepatology 2025; 81(2) doi: 10.1097/HEP.0000000000000852
|
| 10 |
Feng Chen, Qianhui Li, Xiaomin Xu, Fei Wang. Non-invasive Diagnostic Indicators and Antiviral Treatment Efficacy in CHB Patients with Different Liver Histopathological Degrees. Hepatitis Monthly 2024; 24(1) doi: 10.5812/hepatmon-147016
|
| 11 |
Maria Guido, Alessandra Mangia, Neil D. Theise. MacSween's Pathology of the Liver. 2024; doi: 10.1016/B978-0-7020-8228-3.00006-5
|
| 12 |
Antonella Berardicurti, Settimio D’Andrea, Francesco Cipollone, Onorina Berardicurti, Cosima Schiavone, Andrea Boccatonda. Effects of glucagon-like peptide-1 receptor agonists and dual glucagon-like peptide-1 receptor agonists/glucose-dependent insulinotropic polypeptide on liver stiffness and steatosis evaluated through Fibroscan®: a systematic review and meta-analysis. Internal and Emergency Medicine 2026; doi: 10.1007/s11739-026-04384-0
|
| 13 |
Haiyan Fu, Hongjuan Li, Yingrong Du, Chunyun Liu, Futao Dang, Xuan Zhang, Danqing Xu, Yachao Mao, Li Feng Wang, Yu Luo, Li Liu. Factors influencing pathological changes in the liver tissue in hepatitis B virus carriers with low-level viremia. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7) doi: 10.1016/j.clinre.2024.102351
|
| 14 |
Purva Gopal, Xiaobang Hu, Marie E. Robert, Xuchen Zhang. The evolving role of liver biopsy: Current applications and future prospects. Hepatology Communications 2025; 9(1) doi: 10.1097/HC9.0000000000000628
|
| 15 |
Bochao Liu, Jieting Huang, Hualong Yang, Qiao Liao, Min Wang, Ru Xu, Zhengang Shan, Huishan Zhong, Fengfang Liao, Tingting Li, Chengyao Li, Huaqin Liang, Yongshui Fu, Xia Rong, Alexander V. Ivanov. HBcAg-Induced IL-17F drives liver fibrosis in occult HBV infection. Microbiology Spectrum 2026; 14(8) doi: 10.1128/spectrum.04235-25
|
| 16 |
Leona Radmanić, Petra Šimičić, Kristian Bodulić, Adriana Vince, Snjezana Zidovec-Lepej. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C. Cytokine 2024; 176 doi: 10.1016/j.cyto.2024.156529
|
| 17 |
Sanad Dawod, Kimberly Brown. Non-invasive testing in metabolic dysfunction-associated steatotic liver disease. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1499013
|
| 18 |
Gokhan Koker. Reinterpreting Early Liver Stiffness Decline in Chronic Hepatitis B. Journal of Clinical Gastroenterology 2025; 59(7) doi: 10.1097/MCG.0000000000002208
|
| 19 |
Walaa Abdelhamed, Mohamed Elbadry, Mohamed El-Kassas. Evolving B-mode ultrasound-based techniques for assessing metabolic dysfunction-associated steatotic liver disease: Now and beyond. Liver Research 2026; 10(2) doi: 10.1016/j.livres.2026.05.001
|
| 20 |
Na‐Ling Kang, Ya‐Hong Gao, Meng‐Xin Lin, Lu‐Ying Wu, Xiang‐Yang Ye, Hui‐Ming Lin, Qing‐Fa Ruan, Shuo Lin, Hao‐Hang Liu, Ling‐Ling Huang, Jia‐Ji Jiang, Yu‐Rui Liu, Qi Zheng, Ri‐Cheng Mao, Da‐Wu Zeng. Development a novel nomogram model for predicting significant hepatic histological changes in chronic hepatitis B virus carriers. Journal of Medical Virology 2023; 95(7) doi: 10.1002/jmv.28943
|
| 21 |
Li-Yan Lin, Da-Wu Zeng, Yu-Rui Liu, Yue-Yong Zhu, Ling-Ling Huang. Diagnostic value of liver stiffness measurement combined with risk scores for esophagogastric variceal bleeding in patients with hepatitis B cirrhosis. European Journal of Radiology 2024; 173 doi: 10.1016/j.ejrad.2024.111385
|
| 22 |
Asgeir Johannessen, Dag Henrik Reikvam, Soo Aleman, Nega Berhe, Nina Weis, Hailemichael Desalegn, Tore Stenstad, Lars Heggelund, Ellen Samuelsen, Lars Normann Karlsen, Karin Lindahl, Frank Olav Pettersen, Jonas Iversen, Elisabeth Kleppa, Signe Bollerup, Anni Assing Winckelmann, Pascal Brugger‐Synnes, Hans Erling Simonsen, Jan Svendsen, Anne‐Marte Bakken Kran, Marte Holmberg, Inge Christoffer Olsen, Corina Silvia Rueegg, Olav Dalgard. Clinical trial: An open‐label, randomised trial of different re‐start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B. Alimentary Pharmacology & Therapeutics 2024; 60(4) doi: 10.1111/apt.18147
|
| 23 |
Jennifer Audsley, Anchalee Avihingsanon, Xin Li, Rosalind Edwards, Kathy Jackson, Nadia Warner, Olivia Maslac, Peter A Revill, Hay Mar Su Lwin, Sivaporn Gatechompol, Nagalingeswaran Kumarasamy, Tim Spelman, Iskandar Azwa, Adeeba Kamarulzaman, Sharon R Lewin, Joe Sasadeusz. Kinetics and Predictors of Hepatitis B Surface Antigen Loss After Commencing Hepatitis B Virus (HBV)–Active Antiretroviral Therapy in the Setting of HIV and Chronic HBV Coinfection. Clinical Infectious Diseases 2026; 82(1) doi: 10.1093/cid/ciaf281
|
| 24 |
Kaiping Jiang, Lei Zhang, Jianhong Li, Hongtao Hu, Qinghua Huang, Tengyu Qiu, Xiaoai Mo, Jian Ren, Wenqiang Guo, Yin Tao, Haijun Cui, Ying Zuo, Xuli Chen, Youqing Xie, Yanxing Li, Haimin Liang, Zhaohong Liu, Le Xie, Rongjun Mao, Qunfang Jiang, Kaizhou Huang. Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02108-0
|
| 25 |
Dmitry V. Garbuzenko. Diagnostic and risk stratification aspects of liver fibrosis progression in chronic hepatitis B and C viral infection. Medical Journal of the Russian Federation 2021; 27(4) doi: 10.17816/0869-2106-2021-27-4-373-384
|
| 26 |
Xian He, Ming-Xi Zhou, Cheng Cheng, Shan-Shan Li, Yuan Gao, Zhi-Tao Ma, Xin-Hua Song, Zhao-Fang Bai, Zheng-Sheng Zou, Xiao-He Xiao, Jia-Bo Wang, Ya-Wen Lu. Metabolomic Profiling for Histologically Fibrotic Stage in Chronic Drug-Induced Liver Injury. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.896198
|
| 27 |
Adam P. Buckholz, Robert S. Brown. Noninvasive Fibrosis Testing in Chronic Liver Disease Including Caveats. Clinics in Liver Disease 2023; 27(1) doi: 10.1016/j.cld.2022.08.008
|
| 28 |
Syed Ahmed, Sanchit Sharma, Samagra Agarwal, Yu Jun Wong, Martin Putera, Anoop Saraya. Utility of different Baveno criteria to detect esophageal varices irrespective of their size in patients with compensated cirrhosis. Indian Journal of Gastroenterology 2024; 43(3) doi: 10.1007/s12664-023-01458-1
|
| 29 |
Daisuke Miura, Hiromi Suenaga, Kiyoshi Ichihara. The Utility of a Novel Stacked Microvascular Imaging for Enhanced Detection of Fibrosis in Chronic Liver Diseases. Ultrasound in Medicine & Biology 2024; 50(7) doi: 10.1016/j.ultrasmedbio.2024.03.005
|
| 30 |
Chinmay Bera, Nashla Hamdan-Perez, Keyur Patel. Non-Invasive Assessment of Liver Fibrosis in Hepatitis B Patients. Journal of Clinical Medicine 2024; 13(4) doi: 10.3390/jcm13041046
|
| 31 |
Antonio Liguori, Mirko Zoncapè, Giovanni Casazza, Philippa Easterbrook, Emmanuel A Tsochatzis. Staging liver fibrosis and cirrhosis using non-invasive tests in people with chronic hepatitis B to inform WHO 2024 guidelines: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology 2025; 10(4) doi: 10.1016/S2468-1253(24)00437-0
|
| 32 |
Mingwei Li, Mingjie Yao, Leijie Wang, Yanna Liu, Dong Ji, Yongping Yang, Fengmin Lu. The Early On-treatment Stiffness Decline Attributed to the Improved Hepatic Inflammation in Fibrotic Chronic Hepatitis B. Journal of Clinical Gastroenterology 2025; 59(5) doi: 10.1097/MCG.0000000000002032
|
| 33 |
Won-Mook Choi, Ji Won Han, Tae Hyung Kim, Miyoung Choi, Moon Haeng Hur, Hyo Young Lee, Han Ah Lee, Byeong Geun Song, Heechul Nam, Jeong-Ju Yoo, Chang Hun Lee, Gi-Ae Kim, Hye Won Lee, Gwang Hyeon Choi, Young Eun Chon, Yun Bin Lee, Dong Hyun Sinn, Bo Hyun Kim, In Hee Kim. KASL clinical practice guidelines for management of chronic hepatitis B Endorsed by the East Asia Liver Alliance (EALA). Clinical and Molecular Hepatology 2026; 32(3) doi: 10.3350/cmh.2026.0579
|